EN
HI
Summary
As of 12 Oct, 2026, Lupin stock price is ₹1935. During the trading session, the stock has moved between an intraday low of ₹1933.20 and an intraday high of ₹1964.90. Over the last 52 weeks, Lupin has traded between ₹1900.00 and ₹2529.50.
The stock has recorded a trading volume of 4,18,279 shares,. Its Average Traded Price (ATP) is ₹1944.28, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹1935.00.
Lupin has an upper circuit limit of ₹2152.10 and a lower circuit limit of ₹1760.90. The total value traded stands at ₹81.33 CR, and the delivery percentage for the day is 37.22%.
The stock is currently traded with a market lot size of 1. Lupin also offers a dividend yield of 0.92%.
Lupin Share Price Chart
Lupin Share Key Metrics
Volume
4.18 L
Market Cap
88485.61 CR
LTQ@LTP
1@1935.00
ATP
1944.28
Var Margin
12.5 %
Circuit Range
1760.9-2152.1
Delivery %
37.22 %
Value
81.33 CR
ASM/GSM
No
Market Lot
1
Lupin Fundamentals
P/E Ratio
16.21
P/B Ratio
3.77
Div. Yield
0.92
Sector P/E
41.33
Sector P/B
3.45
Sec. Div. Yield
0.53
Lupin Resistance and Support
Pivot 1955.8
Resistance
First Resistance
1969.6
Second Resistance
1982.7
Third Resistance
1996.5
Support
First Support
1942.7
Second Support
1928.9
Third Support
1915.8
Lupin Futures & Options
Lupin Option Chain
View Price, OI, Greeks & More...
27OCT26
1944.50
-13.20 (0.67%)
23NOV26
1959.40
-9.70 (0.49%)
29DEC26
1970.00
-6.80 (0.34%)
LUPIN|27OCT26 CE 1920.00
49.00
-8.9 (-15.37%)
LUPIN|27OCT26 PE 1940.00
32
3.6 (12.68%)
Lupin Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Oct 12 2026 | 1955.9 | 1935 | -1.10% | 1964.9 | 1933.2 |
| Fri Oct 09 2026 | 1948 | 1956.5 | 1.01% | 1968.9 | 1942 |
| Thu Oct 08 2026 | 2012.9 | 1936.9 | -3.78% | 2020.9 | 1936.9 |
Lupin Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-06 | Quarterly Results |
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-02-12 | Quarterly Results |
| 2025-11-06 | Quarterly Results & Others |
| 2025-08-05 | Quarterly Results & Others |
| 2025-05-14 | Audited Results & Final Dividend |
| 2025-02-11 | Quarterly Results & Others |
| 2024-11-07 | Quarterly Results |
| 2024-08-06 | Quarterly Results |
Lupin News
Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Lupin has secured US FDA approval for its ANDA for Phytonadione Injectable Emulsion USP. The drug, indicated for treating low blood clotting, has an estimated annual US market size of USD 52.3 million.
Oct 08 2026 20:58:27
Lupin Ltd - 500257 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Lupin launched Formoflo-G MDI, the world's first fixed-dose triple combination inhaler for COPD management in India, after receiving DCGI approval. The product combines three therapies in a single inhaler for twice-daily use.
Oct 06 2026 09:36:50
Read More
Lupin Management
| Name | Position |
|---|---|
| Manju D Gupta | Chairperson |
| Nilesh Gupta | Managing Director |
Lupin Similar Stocks
Cipla Ltd.
1311.30
10.30 (0.79%)
Mankind Pharma Ltd.
2400.00
31.50 (1.33%)
Dr. Reddy's Laboratories Ltd.
1229.40
32.40 (2.71%)
Aurobindo Pharma Ltd.
1706.90
13.90 (0.82%)
Manipal Health Enterprises Ltd.
679.05
-22.25 (3.17%)
Max Healthcare Institute Ltd.
865.95
-17.85 (2.02%)
Alkem Laboratories Ltd.
5205.00
-74.00 (1.40%)
Glenmark Pharmaceuticals Ltd.
2283.00
-10.00 (0.44%)
Aster DM Quality Care Ltd.
679.40
-20.45 (2.92%)
Fortis Healthcare Ltd.
757.25
-29.00 (3.69%)
Lupin FAQs
The Buying Price of Lupin share is 1935 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Lupin stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Lupin, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Lupin shares is 16.21. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Lupin shares is 3.77. Useful to assess the stock's value relative to its book value.
To assess Lupin’s valuation compare Sector P/E, P/B which are 41.33 & 3.45 with sector averages, along with growth rates and financial metrics.
The Market Cap of Lupin is 88485.61 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Lupin share price is 2529.50 & 1900.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Lupin belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in LUPIN
